New afib guideline recommends a more comprehensive stroke risk calculator and includes novel anticoagulants as treatment options | ACP Hospitalist Weekly | ACP Hospitalist
A new guideline for managing nonvalvular atrial fibrillation recommends using the CHA2DS2-VASc stroke risk calculator, and adds 3 new anticoagulants as treatment options.
Details on the approval of dabigatran etexilate, and more.
Oral anticoagulants compared for risk of recurrent VTE, major bleeds | ACP Hospitalist Weekly | ACP Hospitalist
All oral anticoagulants and antiplatelet agents reduced recurrence of venous thromboembolism (VTE) compared with placebo, with aspirin reducing risk the least and vitamin K antagonists reducing it the most, a meta-analysis found.
Details on anticoagulant regulation and more.
New-generation anticoagulants associated with bleeding after ACS in patients on antiplatelet therapy | ACP Hospitalist Weekly | ACP Hospitalist
New-generation anticoagulants are associated with increased bleeding risk when used after acute coronary syndrome (ACS) in patients taking antiplatelet agents, according to a new meta-analysis.
A 46-year-old woman with no history of pregnancy is evaluated for follow-up monitoring of pulmonary emboli that developed 13 months ago... and other cases.
Extended anticoagulant treatment appears beneficial for first unprovoked PE | ACP Hospitalist Weekly | ACP Hospitalist
Eighteen months of warfarin after PE reduced recurrences during anticoagulation, but showed a similar thromboembolism rate as placebo at 42 months, a randomized trial found.
S. aureus, anticoagulants raise risk of endocarditis complications | ACP Hospitalist Weekly | ACP Hospitalist
In patients with infective endocarditis, four significant risk factors were associated with all neurological complications, while antimicrobial therapy reduced the risk, a new study found.
Aspirin appears to reduce recurrence of VTE after stopping anticoagulants | ACP Hospitalist Weekly | ACP Hospitalist
Aspirin reduced the risk of venous thromboembolism (VTE) recurrence with no apparent increase in major bleeding in patients who had an initial unprovoked VTE and had discontinued anticoagulant treatment, a study found.
Details on the latest recalls, warnings, and approvals.